Clinical Trial Update: Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing Lymphoseek to Albumin Nanocolloid in head and neck cancers, melanoma, and breast cancer is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Head and Neck Cancer
• Melanoma

Drugs mentioned

• Albumin Nanocolloid (null)
• Lymphoseek (tilmanocept)

Snippet

Sponsor: Anna Cruceta | Conditions: Head Cancer, Neck Cancer | Phase 4 | Status: UNKNOWN